Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.20.1
Condensed Balance Sheets - USD ($)
Sep. 30, 2019
Mar. 31, 2019
Current assets:    
Cash & cash equivalents $ 99,447
Accounts receivable 24,788 24,788
Prepaid & other current assets 84,444 66,878
Total current assets 109,232 191,113
Property and equipment, net 110,257 102,378
Intangible assets, net 255,207 275,407
Deferred offering costs 155,311 104,141
TOTAL ASSETS 630,007 673,039
Current liabilities:    
Accounts payable 939,622 517,807
Accrued expenses 350,443 95,040
Accrued interest 306,994 130,101
Cash overdraft 8,207
Notes payable, net of debt discount 2,736,907 1,926,117
Warrant liability 1,462,624 1,398,617
Related party payable 31,000
Total current liabilities 5,835,797 4,067,682
Total liabilities 5,835,797 4,067,682
Commitments and Contingencies (Note 12)
STOCKHOLDERS' DEFICIT:    
Preferred stock, par value $0.0001; 50,000,000 shares authorized, no shares outstanding
Common stock, par value $0.0001; 200,000,000 shares authorized; 16,396,000 shares outstanding as of September 30, 2019 and 9,875,000 shares outstanding as of March 31, 2019 1,640 988
Additional paid-in capital 6,663,488 3,448,857
Accumulated deficit (11,870,918) (6,844,488)
Total stockholders' deficit (5,205,790) (3,394,643)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 630,007 $ 673,039